Status:
COMPLETED
ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159
Lead Sponsor:
Alberta Health services
Conditions:
Peripheral Stem Cell/Marrow Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Evaluate recovery time on 2.5 mg/Kg/day dose of G-CSF versus 5 mg/Kg/day dose.
Eligibility Criteria
Inclusion
- over age 18
- autologous stem cell/marrow transplant candidate in MM, lymphoma, AMG and testicular
Exclusion
- age below 18 years
- sensitive to G-CSF
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00168168
Start Date
July 1 2003
End Date
February 1 2007
Last Update
February 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada